THE DUKE-NUS GRADUATE MEDICAL SCHOOL Singapore has partnered with ImaginAb Inc. to establish a joint corporate laboratory to develop new in vivo molecular imaging agents to study cancer biology and immune function.
NORTH SHORE-LIJ CANCER INSTITUTE opened a $47 million radiation therapy facility.
MARGARET DIMOND was named president of the Karmanos Cancer Hospital, effective immediately.
JOHN CZAJKOWSKI, NCI deputy director for management, has accepted a position as executive dean of administration at Harvard Medical School. His start date will be June 2.
ISSAM MAKHOUL was named the inaugural recipient of the Laura F. Hutchins, M.D. Distinguished Chair for Hematology and Oncology at the University of Arkansas for Medical Sciences.
AVEO ONCOLOGY and Astellas Pharma Inc. will end an agreement to develop the investigational cancer drug tivozanib by Aug. 11.
JIM ALLISON has been awarded the 2014 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.
THE AMERICAN CANCER SOCIETY added five new officers to its 2014 national volunteer board of directors. Pamela Meyerhoffer, a 40-year volunteer with the society, will chair the new board.
JOHN WALTER, president and CEO of The Leukemia & Lymphoma Society since 2008, has stepped down.
FRASER SYMMANS was named director of the CALGB Alliance Translational Research Program. He will oversee the activities of all scientific and administrative committees.
